Short communication: Evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France: ANRS CO06 PRIMO cohort

AIDS Research and Human Retroviruses

Volumn 26, Issue 6, 2010, Pages 645-651

  Galimand, Julie ^a,b   Frange, Pierre ^a,b   Rouzioux, Christine ^a,b   Deveau, Christiane ^c   Avettand Fenoël, Véronique ^a,b   Ghosn, Jade ^a,d   Lascoux, Caroline ^e   Goujard, Cécile ^d   Meyer, Laurence ^c   Chaix, Marie Laure ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c INSERM   (France)

^d BICÊTRE HOSPITAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

POL PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; FEMALE; FRANCE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TYPING; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; GENETIC RECOMBINATION; GENETICS; GENOTYPE; HIV INFECTIONS; ISOLATION AND PURIFICATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; SEQUENCE HOMOLOGY; VIROLOGY;

CLUSTER ANALYSIS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; FRANCE; GENETIC VARIATION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGENY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RECOMBINATION, GENETIC; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY;

EID: 77954181823     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0201     Document Type: Article

References (23)

1. Robertson DL, Anderson JP, Bradac JA, et al.: HIV-1 nomenclature proposal. Science 2000;288(5463):55-56.
2. Konings FA, Haman GR, Xue Y, et al.: Genetic analysis of HIV-1 strains in rural eastern Cameroon indicates the evolution of second-generation recombinants to circulating recombinant forms. J Acquir Immune Defic Syndr 2006;42(3): 331-341.
3. Chaix ML, Descamps D, Wirden M, et al.: Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France. AIDS 2009; 23(6):717-724.
4. Semaille C, Barin F, Cazein F, et al.: Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: Experience after 2 years in France. J Infect Dis 2007;196(3):377-383.
5. Brennan CA, Bodelle P, Coffey R, et al.: HIV global surveillance: Foundation for retroviral discovery and assay development. J Med Virol 2006;78(Suppl 1):S24-S29.
6. Buonaguro L, Tornesello ML, and Buonaguro FM: Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: Pathogenetic and therapeutic implications. J Virol 2007;81(19):10209-10219.
7. Katzenstein D: Diversity, drug resistance, and the epidemic of subtype C HIV-1 in Africa. J Infect Dis 2006;194(Suppl 1):S45-S50.
8. Goujard C, Bonarek M, Meyer L, et al.: CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin Infect Dis 2006;42(5):709-715.
9. Pasquier C, Millot N, Njouom R, et al.: HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods 2001;94(1-2):45-54.
10. Delwart EL, Shpaer EG, Louwagie J, et al.: Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes. Science 1993;262(5137): 1257-1261.
11. Alizon M, Wain-Hobson S, Montagnier L, and Sonigo P: Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients. Cell 1986; 46(1):63-74.
12. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG: The CLUSTAL-X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25(24): 4876-4882.
13. Felsenstein J: Taking variation of evolutionary rates between sites into account in inferring phylogenies. J Mol Evol 2001; 53(4-5):447-455.
14. Page RD: TreeView: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996;12(4): 357-358.
15. Salminen MO, Carr JK, Burke DS, and McCutchan FE: Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 1995;11(11):1423-1425.
16. Vidal N, Frange P, Chaix ML, et al.: Characterization of an old complex circulating recombinant form, CRF27-cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France. AIDS Res Hum Retroviruses 2008;24(2):315-321.
17. Frange P, Galimand J, Vidal N, et al.: New and old complex recombinant HIV-1 strains among patients with primary infection in 1996-2006 in France: The French ANRS CO06 primo cohort study. Retrovirology 2008; 5:69.
18. Sankale JL, Langevin S, Odaibo G, et al.: The complexity of circulating HIV type 1 strains in Oyo state, Nigeria. AIDS Res Hum Retroviruses 2007;23(8):1020-1025.
19. Bartolo I, Rocha C, Bartolomeu J, et al.: Highly divergent subtypes and new recombinant forms prevail in the HIV=AIDS epidemic in Angola: New insights into the origins of the AIDS pandemic. Infect Genet Evol 2008;9(4):672-682.
20. Yebra G, Rivas P, Herrero MD, et al.: Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007). AIDS Res Hum Retroviruses 2009;25(1):37-44.
21. Fleury H, Recordon-Pinson P, Caumont A, et al.: HIV type 1 diversity in France, 1999-2001: Molecular characterization of non-B HIV type 1 subtypes and potential impact on susceptibility to antiretroviral drugs. AIDS Res Hum Retroviruses 2003;19(1):41-47.
22. Lospitao E, Alvarez A, Soriano V, and Holguin A: HIV-1 subtypes in Spain: A retrospective analysis from 1995 to 2003. HIV Med 2005;6(5):313-320.
23. Paraskevis D, Pybus O, Magiorkinis G, et al.: Tracing the HIV-1 subtype B mobility in Europe: A phylogeographic approach. Retrovirology 2009;6(1):49.